Your Collaborative Forum to Shape the Future of Dermatology
Accelerating Breakthroughs in Immunodermatology Drug Development
The Dermatology Drug Development Summit Europe returns for its 6th year as the premier industry forum dedicated to advancing next-generation immunodermatology therapies. With regulatory breakthroughs reshaping the landscape—such as Eli Lilly’s IL-13 inhibitor and LEO Pharma’s topical JAK-I—2024 was a pivotal year for the industry to accelerate innovation.
Join 80+ senior leaders from Sanofi, Alys Pharmaceuticals, Moonlake Immunotherapeutics, and more to:
- Explore cutting-edge strategies
- Address clinical challenges
- Optimise patient recruitment to fast-track regulatory approval and maximise market success
With dermatology drug development entering an era of increased competition and complexity, now is the time to collaborate, gain exclusive insights, and refine your pipeline strategy to meet urgent unmet needs in Hidradenitis Suppurativa, Vitiligo, Alopecia, Pemphigus, and beyond.
World-Class Speaker Faculty Include:






Previously Attending Companies Include:

What Did Past Attendees Have to Say?
“The size and amount of participation at the summit made it perfect for networking and conference attendance”
Sol-Gel Technologies
“The intimate and transparent atmosphere, the dedicated networking sessions, the relevance and quality of the presentations and the number of dermatology leaders attending were all great.“
Sanos Group
“I enjoyed attending and speaking at the summit. It is a great way to network. I enjoy the round table discussions and exposure to various facets of drug discovery“
Merck & Co
“"The Dermatology Drug Development Summit is a vibrant forum for the presentation of innovation and ideas amongst experts who understand the unique opportunities and challenges of treating dermatologic disease. I am looking forward to the excitement and energy of discussions within the group to advance the field.“
Arcutis Biotherapeutics